|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Genocea Biosciences, Inc. (GNCA) |
|
|
$0.59 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
51,640,000 |
Market
Cap: |
30.69(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.5943 - $0.5943 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. GEN-011 is an investigational solid tumor cell therapy candidate comprised of CD4+ and CD8+ neoantigen-targeted peripheral T cells. GEN-011 is comprised of T cells extracted from the patient's peripheral blood and specific for ATLAS-prioritized neoantigens. GEN-009 is an investigational neoantigen vaccine delivering adjuvanted synthetic long peptides from ATLAS-identified neoantigens.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
93,582,981 |
Total Sell Value |
$0 |
$0 |
$0 |
$6,768,648 |
Total People Sold |
0 |
0 |
0 |
15 |
Total Sell Transactions |
0 |
0 |
0 |
27 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Makhzoumi Mohamad |
10% Owner |
|
2019-02-14 |
4 |
B |
$0.47 |
$4,688,619 |
I/I |
9,948,269 |
34,948,269 |
1.5 |
- |
|
Florence Anthony A. Jr. |
10% Owner |
|
2019-02-14 |
4 |
B |
$0.47 |
$4,688,619 |
I/I |
9,948,269 |
34,948,269 |
1.5 |
- |
|
Barris Peter J |
10% Owner |
|
2019-02-14 |
4 |
B |
$0.47 |
$4,688,619 |
I/I |
9,948,269 |
34,948,269 |
1.5 |
- |
|
Alfieri Michael |
Principle Financial Officer |
|
2018-09-13 |
4 |
B |
$0.54 |
$5,400 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
Siber George |
Director |
|
2018-09-07 |
4 |
B |
$0.61 |
$8,174 |
D/D |
13,400 |
165,417 |
2.39 |
- |
|
Siber George |
Director |
|
2018-09-06 |
4 |
B |
$0.61 |
$15,250 |
D/D |
25,000 |
152,017 |
2.39 |
- |
|
Siber George |
Director |
|
2018-09-05 |
4 |
B |
$0.62 |
$15,500 |
D/D |
25,000 |
127,017 |
2.39 |
- |
|
Siber George |
Director |
|
2018-09-04 |
4 |
B |
$0.62 |
$15,500 |
D/D |
25,000 |
102,017 |
2.39 |
- |
|
Siber George |
Director |
|
2018-08-31 |
4 |
B |
$0.61 |
$15,250 |
D/D |
25,000 |
77,017 |
2.39 |
- |
|
Siber George |
Director |
|
2018-08-30 |
4 |
B |
$0.61 |
$15,250 |
D/D |
25,000 |
52,017 |
2.39 |
- |
|
Siber George |
Director |
|
2018-08-29 |
4 |
B |
$0.61 |
$15,250 |
D/D |
25,000 |
27,017 |
2.39 |
- |
|
Clark William D |
President and CEO |
|
2018-01-17 |
4 |
B |
$0.80 |
$20,000 |
D/D |
25,000 |
82,931 |
2.81 |
- |
|
Poole Jonathan |
Chief Financial Officer |
|
2017-07-24 |
4 |
AS |
$6.00 |
$270,000 |
D/D |
(45,000) |
39,247 |
|
- |
|
Poole Jonathan |
Chief Financial Officer |
|
2017-07-24 |
4 |
OE |
$3.09 |
$139,050 |
D/D |
45,000 |
84,247 |
|
- |
|
Siber George |
Director |
|
2017-05-19 |
4 |
S |
$6.07 |
$135,282 |
D/D |
(22,287) |
2,017 |
|
- |
|
Siber George |
Director |
|
2017-05-19 |
4 |
OE |
$2.38 |
$58,350 |
D/D |
22,287 |
24,304 |
|
- |
|
Siber George |
Director |
|
2017-05-18 |
4 |
S |
$6.02 |
$186,891 |
D/D |
(31,045) |
2,017 |
|
- |
|
Siber George |
Director |
|
2017-05-18 |
4 |
OE |
$1.67 |
$66,727 |
D/D |
31,045 |
33,062 |
|
- |
|
Poole Jonathan |
Chief Financial Officer |
|
2017-05-10 |
4 |
D |
$6.13 |
$21,455 |
D/D |
(3,500) |
39,247 |
|
- |
|
Poole Jonathan |
Chief Financial Officer |
|
2017-05-08 |
4 |
S |
$6.51 |
$40,447 |
D/D |
(6,213) |
42,747 |
|
- |
|
Poole Jonathan |
Chief Financial Officer |
|
2017-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,747 |
48,960 |
|
- |
|
Hetherington Seth V |
Chief Medical Officer |
|
2016-11-09 |
4 |
OE |
$2.02 |
$10,100 |
D/D |
5,000 |
26,000 |
|
- |
|
Hoffman Eric S |
Chief Business Officer |
|
2016-11-08 |
4 |
B |
$3.59 |
$10,770 |
D/D |
3,000 |
11,790 |
2.74 |
- |
|
Poole Jonathan |
Chief Financial Officer |
|
2016-11-07 |
4 |
B |
$3.34 |
$23,380 |
D/D |
7,000 |
17,213 |
2.74 |
- |
|
Hoffman Eric S |
Chief Business Officer |
|
2016-11-07 |
4 |
B |
$3.41 |
$13,640 |
D/D |
4,000 |
8,790 |
2.74 |
- |
|
182 Records found
|
|
Page 5 of 8 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|